Blindness from suprachoroidal haemorrhage in two patients with age-related macular degeneration on systemic anticoagulation therapy or an antiplatelet agent.

The Medical Journal of Australia ISSN: 0025729X 15 March 2010 192 6 346-347 ©The Medical Journal of Australia 2010 www.mja.com.au Lessons from Practice leading to subretinal bleeding, fibrous scar formatio visual loss. Many older patients who have AMD also take me can exacerbate or promote bleeding, such as anti antiplatelet agents. In rare cases, intraocular bleed form of subretinal, suprachoroidal, or vitreous hae ge-related macular degeneration affects about one-third of people aged over 75 years. Of those with AMD, 10%–15% develop the neovascular (“wet”) form, characterised by abnormal new blood vessel formation in the choroid, under the retina. These abnormal vascular membranes are prone to rupture, n and severe